Conversion from regional to systemic chemotherapy

Hepatic artery chemotherapy for the ambulatory patient using the Infusaid pump has been advocated for the management of malignant hepatic disease. Catheter related complications remain a potential source of morbidity particularly when the transaxillary approach is used. Should hepatic artery catheter related complications arise, the possibility of conversion to a systemic route offers the opportunity to salvage the Infusaid pump.